Senior Director, Global Biological Policy and Programs
Countries need to work together to control pandemics, but without an independent assessment of national health security capability, it is difficult to fully understand needs, identify gaps, and track improvements over time.
Create a Global Health Security (GHS) Index to assess country capability to prevent and mitigate high-consequence biological events.
The GHS Index highlights individual country needs, boost compliance with international standards, and create better understanding of global capabilities to prevent, detect, and respond to biological threats.
Recent infectious disease outbreaks—including the Zika virus in the Americas, the Ebola outbreak in West Africa, MERS-CoV in the Middle East, and pandemic influenza—have exposed weaknesses in preventing, detecting, and responding to biological threats. Without adequate measures to address public health emergencies, outbreaks can rapidly spread, costing thousands of lives and billions in economic loss. Ultimately, this threatens global peace and security.
NTI and the Johns Hopkins Center for Health Security, with research by The Economist Intelligence Unit (EIU), are developing a Global Health Security (GHS) Index that provides a public benchmarking of health security and related capabilities across the 195 countries that make up the States Parties to the International Health Regulations. Learning lessons from NTI’s Nuclear Security Index, the GHS Index will be a valuable tool to spur measurable changes in national health security and improve international capability to address one of the world’s most omnipresent risks: infectious disease outbreaks that can lead to international epidemics and pandemics. The GHS Index draws from and complements the World Health Organization Joint External Evaluation process and is intended to influence decision-making; motivate regular country commitments, financing, and accountability; and—ultimately—to aid the improvement of pandemic preparedness.
In consultation with an international panel of experts that includes 21 widely respected scientists and public health experts from 13 countries and international organizations including the World Bank, the project team has developed a framework of national indicators for health security. It assesses countries’ technical, financial, and political capabilities to prevent, detect, and respond to epidemics with international implications.
The GHS Index helps decisionmakers in individual countries, regional and international organizations, and philanthropies to act now to identify, fill, and finance capability gaps. Over time, the GHS Index will measure progress against benchmarks, promote mutual accountability, encourage transparency, and provide incentives for improvements.
International Panel of Experts
Note: Members of the Global Health Security (GHS) Index International Panel of Experts provided advice over the course of the Index’s development and participated in their personal capacities or in their capacities as representatives of advising organizations. The judgments and recommendations reflected in the GHS Index do not necessarily reflect the views of panel members, nor their respective employers, other affiliations, or governments.
Dr. David M. Barash
Executive Director, GE Foundation
Dr. David Blazes
Senior Program Officer, Surveillance and Epidemiology, Global Health Program, Bill & Melinda Gates Foundation
Dr. Mukesh Chawla
Adviser, Health, Nutrition and Population, World Bank; Chair, UNAIDS and World Bank Global Economics Reference Group on HIV-AIDS
Dr. Chaeshin Chu
Deputy Scientific Director, Division of Risk Assessment and International Cooperation, Korea Centers for Disease Control and Prevention (KCDC)
Dr. Scott F. Dowell
Deputy Director, Vaccine Development and Surveillance, Global Health Program, Bill & Melinda Gates Foundation
Dr. Dylan George
Associate Director, BNext, In-Q-Tel
Mr. Lawrence O. Gostin
Faculty Director and Founding Chair, O’Neill Institute for National and Global Health Law, Georgetown University Law Center
Dr. Ernesto Gozzer
Associate Professor, Universidad Peruana Cayetano Heredia; International Consultant
Dr. Wilmot James
Visiting Professor, Political Science and Pediatrics, Columbia University
Dr. Julius J. Lutwama
Senior Principal Research Officer, Ministry of Health, Uganda; Head of the Department of Arbovirology, Emerging and Re-Emerging Viral Infectious Diseases, Uganda Virus Research Institute (UVRI)
Dr. Issa Makumbi
Director, Public Health Emergency Operations Centre, Ministry of Health, Uganda
Dr. Lee Myers
Manager, a.i., Emergency Management Centre for Animal Health (EMC-AH), Food and Agriculture Organization (FAO) of the United Nations (on behalf of the United States Department of Agriculture)
Dr. Indira Nath
Former Senior Professor and Head, Department of Biotechnology, All India Institute of Medical Sciences
Dr. Simo Nikkari
Director and Professor, Centres for Military Medicine and Biothreat Preparedness, FDF Logistics Command, Finland
The Honorable Cllr. Tolbert G. Nyenswah
Director General, National Public Health Institute, Liberia
Mr. Robert Powell
Editorial Director Americas, Thought Leadership, The Economist Intelligence Unit
Dr. Malik Muhammad Safi
Director of Health Programs and Head of Health Planning, System Strengthening and Information Analysis Unit, Ministry of National Health Services, Regulation and Coordination, Pakistan
Dr. Tomoya Saito
Chief Senior Researcher, Department of Health Crisis Management, National Institute of Public Health, Japan
Dr. Pretty Multihartina
Director, Center for Health Determinant Analysist, Ministry of Health, Indonesia
Dr. Oyewale Tomori
Professor of Virology; Former President, Nigerian Academy of Science
Dr. Wu Fan
Deputy Director General, Shanghai Municipal Health Commission, China
| 9 AM EST
NTI submitted a statement to the virtual COVID-19 Summit convened by President Biden, calling for bold, decisive action to stem the devastating impacts of COVID-19 globally.
A leading biochemist and top health advisor to New Zealand’s government says the 2019 Global Health Security (GHS) Index was key to the country’s successful response to the COVID-19 pandemic.
The webinar aimed to inform Latin American decision makers about the GHS Index and the depth of research and international collaboration behind it.
Panel members discussed the importance of laboratory capacity, contact tracing, and political risks in expanding and weighting the pandemic-conscious report.
NTI and partners hosted virutal side events on using the GHS Index as a guide for responding to COVID-19 and on strengthening biosafety and biosecurity.
The Global Health Security Index website has been awarded for its creativity and digital excellence from leading communicators and creative professionals.
A 2020 commentary highlights the value of the Global Health Security Index as a practical tool that can help inform global policy makers and practitioners.
The U.S. was ranked first due to its high-quality labs and scientific staff, Strategic National Stockpile, and emergency distribution and communication plans.
The 2020 NTI Nuclear Security Index finds that progress on protecting nuclear materials from theft and sabotage has slowed significantly over the past two years,
The Global Health Security (GHS) Index demonstrates that the world is not prepared for epidemics and pandemics.
The first comprehensive assessment of global health security capabilities in 195 countries.
The inaugural GHS Index finds severe weaknesses in countries’ abilities to prevent, detect, and respond to significant disease outbreaks and that no country is fully prepared.
The first comprehensive assessment and benchmarking of health security and related capabilities across the 195 countries that make up the States Parties to the International Health Regulations.
An NTI-Johns Hopkins article examines the full scope of academic literature to better identify evidence for measuring health security at the country level.
NTI | bio will create a Global Health Security Index to serve as an assessment of all countries’ capabilities to prevent, detect, and respond to biological events.
NTI experts Beth Cameron and Michelle Nalabandian will join hundreds of government officials and experts for the 71st World Health Assembly in Geneva.
New video makes the case for protecting America’s commitment to global health security.
New Funding from the Bill & Melinda Gates Foundation Accelerates Global Health Security Index.
The interview covers the current state of play in disease control and offers advice on how to find a job where it’s possible to make an impact.
NTI's Biosecurity Program is partnering with the Next Generation GHS Network to launch a competition in preparation for the 4th Annual High Level GHSA Ministerial Meeting.
The Global Health Security Agenda is an irreplaceable and proven mechanism for promoting measurable change in preparedness to prevent and combat biological disease.
NTI's Beth Cameron was one of five advanced reviewers of the report which recommends aggressive action to analyze and finance gaps to stop outbreaks at the source.
NTI will partner on the Index with the Center for Health Security at the Johns Hopkins Bloomberg School of Public Health and the Economist Intelligence Unit.